Overview
Bifunctional PEG linkers are specialized polyethylene glycol derivatives engineered with reactive functional groups at both termini. These compounds serve as molecular bridges, enabling controlled conjugation between biomolecules, nanoparticles, or synthetic polymers. Their modular design allows customization of length (via PEG units) and reactivity (via end-group chemistry), making them indispensable in precision bioconjugation strategies. First developed in the 1990s for protein PEGylation, modern variants now support click chemistry (e.g., DBCO-azide), thiol-maleimide coupling, and NHS ester-amine reactions. The PEG spacer provides hydrophilicity and steric shielding, while the terminal groups dictate conjugation specificity. This dual functionality addresses challenges in drug delivery and diagnostics by improving payload solubility and pharmacokinetics.
Physical and Chemical Properties
Bifunctional PEGs exhibit properties dictated by their polyethylene glycol backbone and terminal groups. The PEG chain confers high water solubility (≥100 mg/mL for most variants) and low immunogenicity, with viscosity increasing proportionally to molecular weight. Thermal stability typically ranges up to 200°C before decomposition, though end groups may degrade earlier (e.g., NHS esters hydrolyze above 40°C). Key metrics include polydispersity index (PDI <1.05 preferred for precision applications) and functional group density (typically >90% substitution). NMR and HPLC are standard characterization methods. The linker's flexibility (PEG's 120° C-O-C bond angle) enhances binding efficiency compared to rigid spacers, while its non-fouling properties minimize nonspecific interactions in biological systems.
Main Applications
In pharmaceuticals, bifunctional PEGs create stable antibody-drug conjugates (ADCs) by linking cytotoxic payloads to monoclonal antibodies via cleavable or non-cleavable bonds. For example, NHS-maleimide PEGs are widely used in ADC development, with the NHS end attaching to lysines on antibodies and maleimide reacting with cysteine-engineered payloads. Beyond therapeutics, they enable surface functionalization in diagnostics (e.g., attaching DNA probes to quantum dots) and tissue engineering (crosslinking hydrogels via azide-alkyne cycloaddition). In material science, they modify nanoparticle surfaces to enhance biocompatibility or create stimuli-responsive materials. Emerging uses include PROTAC linker design and mRNA vaccine formulations, where PEGylation stabilizes lipid nanoparticles.
Safety and Storage
Most bifunctional PEGs are classified as non-hazardous but require careful handling due to reactive end groups. NHS esters and maleimides can cause skin/eye irritation, while azides demand explosion precautions in large quantities. Always use nitrile gloves and work in fume hoods when handling powders. For storage, divide bulk quantities into single-use aliquots under argon or nitrogen to prevent moisture absorption and hydrolysis. Lyophilized powders remain stable for years at -20°C, while liquid formulations (e.g., in DMSO) should be used within 6 months. Monitor for crystallinity changes or discoloration, which indicate degradation. For temperature-sensitive groups like NHS esters, avoid repeated freeze-thaw cycles.
B2B Procurement Guide
When sourcing bifunctional PEG linkers, prioritize suppliers with ISO 9001 certification and batch-specific Certificates of Analysis (CoA). Critical specifications to verify include: 1. Functional group purity (HPLC ≥95%) 2. Moisture content (KF titration <1%) 3. End-cap analysis (e.g., ≤5% mono-functional by NMR) For GMP-grade materials, request endotoxin testing (<0.1 EU/mg) and residual solvent reports. Bulk orders (≥1kg) often qualify for 15-30% discounts, but validate scalability through pilot batches. Lead times vary from 2 weeks (standard products) to 8 weeks (custom synthesis). Consider regional distributors for urgent shipments, though manufacturer-direct purchases ensure better traceability.
Related Manufacturers
- 主营：荧光染料、花青素染料
- 主营：在水中、包含肽、含叠氮、peg单元、peg试剂、aminopeg8、丙炔基、由氨基、菁染料、具有炔、胺hcl盐、阿尔法、催化剂、结构式、氨基nh2、3694-51-7、碘化物、4727-50-8、具有两、带有炔、磺酸基、3065-79-0、甲基九、bcn基团、荧光素
- 主营：反应活、hydrazide、修饰剂、催化剂、糖蛋白、连接子、激动剂、聚合物、活性脂、胆固醇、钆特酸、催化性、dna标记、络合剂、荧光试剂、雨蛙素、乙二胺、ped结构、衍生物、化合物、链接剂、反应物、生物素